Moleculin Biotech, Inc. (MBRX)
NASDAQ
0.4420
+0.02 (+4.25%)
Real-time Data
01:30 PM
Day's Range
0.41300.4560
52 wk Range
0.161015.75
Financial Statements - MBRX - Moleculin Biotech, Inc.
Revenue
0
Net Income
-33.56M▼ 54.2%
EBITDA
-16.47M▲ 46.5%
Free Cash Flow
-22.73M▲ 4.8%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Goods | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | -25.10M | -26.64M | -29.63M | -30.64M | -22.96M | -19.74M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | -8.56M | 4.32M | -1.50M | 1.37M | 6.76M | 2.37M |
| Pre Tax Income | -33.56M | -21.76M | -29.76M | -29.02M | -15.89M | -17.35M |
| Income Tax | - | - | - | - | - | 0 |
| Net Income | -33.56M | -21.76M | -29.76M | -29.02M | -15.89M | -17.35M |
| EPS Basic | -28.42 | -158 | -15.14535 | -15.15 | -8.85 | -26.4 |
| EPS Diluted | -28.42 | -158 | -15.14535 | -15.15 | -8.85 | -26.4 |
| Basic Shares Outstanding | 1.18M | 137.71K | 1.96M | 1.90M | 1.79M | 656.37K |
| Diluted Shares Outstanding | 1.18M | 137.71K | 1.96M | 1.90M | 1.79M | 656.37K |
| Ebit | -25.10M | -26.64M | -29.63M | -30.64M | -22.96M | -19.74M |
| Ebitda | -16.47M | -30.80M | -28.46M | -31.84M | -29.53M | -21.88M |
| Net Income Continuous Operations | -33.56M | -21.76M | -29.76M | -29.02M | -15.89M | -17.35M |
| Minority Interests | - | - | - | - | - | - |
| Preferred Stock Dividends | 104K | - | - | - | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
